Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Jul;85(2):228–234. doi: 10.1054/bjoc.2001.1901

Analysis of differentially expressed genes in human hepatocellular carcinoma using suppression subtractive hybridization

Y Miyasaka 1,2, N Enomoto 1,2, K Nagayama 1,2, N Izumi 4, F Marumo 2, M Watanabe 1, C Sato 3
PMCID: PMC2364030  PMID: 11461082

Abstract

The genetic basis of hepatocellular carcinoma (HCC) has not yet been fully understood. Although various methods have been developed to detect differentially expressed genes in malignant diseases, efficient analysis from clinical specimens is generally difficult to perform due to the requirement of a large amount of samples. In the present study, we analysed differentially expressed genes with a small amount of human HCC samples using suppression subtractive hybridization (SSH). Total RNA were obtained from the hepatitis C virus-associated HCC and adjacent non-HCC liver tissues. cDNA was synthesized using modified RT-PCR, and then tester cDNA was ligated with 2 different kinds of adaptors and hybridized with an excess amount of driver cDNA. Tester specific cDNA was obtained by suppression PCR and the final PCR product was subcloned and sequenced. We identified 7 known genes (focal adhesion kinase, deleted in colon cancer, guanine binding inhibitory protein α, glutamine synthetase, ornithine aminotransferase, M130, and pepsinogen C) and 2 previously unknown genes as being overexpressed in HCC, and 1 gene (decorin) as suppressed in HCC. Quantitative analysis of gene expression using quantitative RT-PCR demonstrated the differential expression of these genes in the original and other HCC samples. These findings demonstrated that it is possible to identify the previously unknown, differential gene expression from a small amount of clinical samples. Information about such alterations in gene expression could be useful for elucidating the genetic events in HCC pathogenesis, developing the new diagnosic markers, or determining novel therapeutic targets. © 2001 Cancer Research Campaign http://www.bjcancer.com

Keywords: suppression subtractive hybridization, hepatocellular carcinoma, focal adhesion kinase, pepsinogen C, decorin

Full Text

The Full Text of this article is available as a PDF (176.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alon U., Barkai N., Notterman D. A., Gish K., Ybarra S., Mack D., Levine A. J. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):6745–6750. doi: 10.1073/pnas.96.12.6745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Balbín M., López-Otín C. Hormonal regulation of the human pepsinogen C gene in breast cancer cells. Identification of a cis-acting element mediating its induction by androgens, glucocorticoids, and progesterone. J Biol Chem. 1996 Jun 21;271(25):15175–15181. doi: 10.1074/jbc.271.25.15175. [DOI] [PubMed] [Google Scholar]
  3. Bratthauer G. L., Fanning T. G. Active LINE-1 retrotransposons in human testicular cancer. Oncogene. 1992 Mar;7(3):507–510. [PubMed] [Google Scholar]
  4. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  5. Christa L., Simon M. T., Flinois J. P., Gebhardt R., Brechot C., Lasserre C. Overexpression of glutamine synthetase in human primary liver cancer. Gastroenterology. 1994 May;106(5):1312–1320. doi: 10.1016/0016-5085(94)90024-8. [DOI] [PubMed] [Google Scholar]
  6. Diatchenko L., Lau Y. F., Campbell A. P., Chenchik A., Moqadam F., Huang B., Lukyanov S., Lukyanov K., Gurskaya N., Sverdlov E. D. Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):6025–6030. doi: 10.1073/pnas.93.12.6025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Diez-Itza I., Merino A. M., Tolivia J., Vizoso F., Sánchez L. M., López-Otín C. Expression of pepsinogen C in human breast tumours and correlation with clinicopathologic parameters. Br J Cancer. 1993 Sep;68(3):637–640. doi: 10.1038/bjc.1993.399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dragani T. A., Manenti G., Della Porta G., Gattoni-Celli S., Weinstein I. B. Expression of retroviral sequences and oncogenes in murine hepatocellular tumors. Cancer Res. 1986 Apr;46(4 Pt 2):1915–1919. [PubMed] [Google Scholar]
  9. Endege W. O., Steinmann K. E., Boardman L. A., Thibodeau S. N., Schlegel R. Representative cDNA libraries and their utility in gene expression profiling. Biotechniques. 1999 Mar;26(3):542-8, 550. doi: 10.2144/99263cr04. [DOI] [PubMed] [Google Scholar]
  10. Fazeli A., Dickinson S. L., Hermiston M. L., Tighe R. V., Steen R. G., Small C. G., Stoeckli E. T., Keino-Masu K., Masu M., Rayburn H. Phenotype of mice lacking functional Deleted in colorectal cancer (Dcc) gene. Nature. 1997 Apr 24;386(6627):796–804. doi: 10.1038/386796a0. [DOI] [PubMed] [Google Scholar]
  11. Frank S., von Specht B. U., Farthmann E. H., Hirsch T. Identification of genes involved in human mesothelial cancer progression using a modified differential display technique. Cancer Lett. 1998 Jan 16;123(1):7–14. doi: 10.1016/s0304-3835(97)00317-0. [DOI] [PubMed] [Google Scholar]
  12. Frisch S. M., Vuori K., Ruoslahti E., Chan-Hui P. Y. Control of adhesion-dependent cell survival by focal adhesion kinase. J Cell Biol. 1996 Aug;134(3):793–799. doi: 10.1083/jcb.134.3.793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gotley D. C., Reeder J. A., Fawcett J., Walsh M. D., Bates P., Simmons D. L., Antalis T. M. The deleted in colon cancer (DCC) gene is consistently expressed in colorectal cancers and metastases. Oncogene. 1996 Aug 15;13(4):787–795. [PubMed] [Google Scholar]
  14. Khan J., Simon R., Bittner M., Chen Y., Leighton S. B., Pohida T., Smith P. D., Jiang Y., Gooden G. C., Trent J. M. Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. Cancer Res. 1998 Nov 15;58(22):5009–5013. [PubMed] [Google Scholar]
  15. Kishi K., Kinoshita Y., Matsushima Y., Okada A., Maekawa T., Kawanami C., Watanabe N., Chiba T. Pepsinogen C gene product is a possible growth factor during gastric mucosal healing. Biochem Biophys Res Commun. 1997 Sep 8;238(1):17–20. doi: 10.1006/bbrc.1997.7231. [DOI] [PubMed] [Google Scholar]
  16. Konishi N., Nakaoka S., Matsumoto K., Nakamura M., Kuwashima S., Hiasa Y., Cho M., Uemura H., Hirao Y. Expression of pepsinogen II with androgen and estrogen receptors in human prostate carcinoma. Pathol Int. 1999 Mar;49(3):203–207. doi: 10.1046/j.1440-1827.1999.00847.x. [DOI] [PubMed] [Google Scholar]
  17. Kornberg L. J. Focal adhesion kinase and its potential involvement in tumor invasion and metastasis. Head Neck. 1998 Dec;20(8):745–752. doi: 10.1002/(sici)1097-0347(199812)20:8<745::aid-hed14>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  18. Kuang W. W., Thompson D. A., Hoch R. V., Weigel R. J. Differential screening and suppression subtractive hybridization identified genes differentially expressed in an estrogen receptor-positive breast carcinoma cell line. Nucleic Acids Res. 1998 Feb 15;26(4):1116–1123. doi: 10.1093/nar/26.4.1116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Liang P., Averboukh L., Keyomarsi K., Sager R., Pardee A. B. Differential display and cloning of messenger RNAs from human breast cancer versus mammary epithelial cells. Cancer Res. 1992 Dec 15;52(24):6966–6968. [PubMed] [Google Scholar]
  20. Matz M., Shagin D., Bogdanova E., Britanova O., Lukyanov S., Diatchenko L., Chenchik A. Amplification of cDNA ends based on template-switching effect and step-out PCR. Nucleic Acids Res. 1999 Mar 15;27(6):1558–1560. doi: 10.1093/nar/27.6.1558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Mehlen P., Rabizadeh S., Snipas S. J., Assa-Munt N., Salvesen G. S., Bredesen D. E. The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis. Nature. 1998 Oct 22;395(6704):801–804. doi: 10.1038/27441. [DOI] [PubMed] [Google Scholar]
  22. Nagasue N., Yu L., Yukaya H., Kohno H., Nakamura T. Androgen and oestrogen receptors in hepatocellular carcinoma and surrounding liver parenchyma: impact on intrahepatic recurrence after hepatic resection. Br J Surg. 1995 Apr;82(4):542–547. doi: 10.1002/bjs.1800820435. [DOI] [PubMed] [Google Scholar]
  23. Osada T., Sakamoto M., Nagawa H., Yamamoto J., Matsuno Y., Iwamatsu A., Muto T., Hirohashi S. Acquisition of glutamine synthetase expression in human hepatocarcinogenesis: relation to disease recurrence and possible regulation by ubiquitin-dependent proteolysis. Cancer. 1999 Feb 15;85(4):819–831. doi: 10.1002/(sici)1097-0142(19990215)85:4<819::aid-cncr9>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  24. Owens L. V., Xu L., Dent G. A., Yang X., Sturge G. C., Craven R. J., Cance W. G. Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer. Ann Surg Oncol. 1996 Jan;3(1):100–105. doi: 10.1007/BF02409059. [DOI] [PubMed] [Google Scholar]
  25. Plasterk R. H., Izsvák Z., Ivics Z. Resident aliens: the Tc1/mariner superfamily of transposable elements. Trends Genet. 1999 Aug;15(8):326–332. doi: 10.1016/s0168-9525(99)01777-1. [DOI] [PubMed] [Google Scholar]
  26. Ritter M., Buechler C., Langmann T., Schmitz G. Genomic organization and chromosomal localization of the human CD163 (M130) gene: a member of the scavenger receptor cysteine-rich superfamily. Biochem Biophys Res Commun. 1999 Jul 5;260(2):466–474. doi: 10.1006/bbrc.1999.0866. [DOI] [PubMed] [Google Scholar]
  27. Robertson H. M., Zumpano K. L., Lohe A. R., Hartl D. L. Reconstructing the ancient mariners of humans. Nat Genet. 1996 Apr;12(4):360–361. doi: 10.1038/ng0496-360. [DOI] [PubMed] [Google Scholar]
  28. Santra M., Skorski T., Calabretta B., Lattime E. C., Iozzo R. V. De novo decorin gene expression suppresses the malignant phenotype in human colon cancer cells. Proc Natl Acad Sci U S A. 1995 Jul 18;92(15):7016–7020. doi: 10.1073/pnas.92.15.7016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Skowronski J., Fanning T. G., Singer M. F. Unit-length line-1 transcripts in human teratocarcinoma cells. Mol Cell Biol. 1988 Apr;8(4):1385–1397. doi: 10.1128/mcb.8.4.1385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Stubbs A. P., Abel P. D., Golding M., Bhangal G., Wang Q., Waxman J., Stamp G. W., Lalani E. N. Differentially expressed genes in hormone refractory prostate cancer: association with chromosomal regions involved with genetic aberrations. Am J Pathol. 1999 May;154(5):1335–1343. doi: 10.1016/S0002-9440(10)65387-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Ständer M., Naumann U., Wick W., Weller M. Transforming growth factor-beta and p-21: multiple molecular targets of decorin-mediated suppression of neoplastic growth. Cell Tissue Res. 1999 May;296(2):221–227. doi: 10.1007/s004410051283. [DOI] [PubMed] [Google Scholar]
  32. Tremblay L., Hauck W., Aprikian A. G., Begin L. R., Chapdelaine A., Chevalier S. Focal adhesion kinase (pp125FAK) expression, activation and association with paxillin and p50CSK in human metastatic prostate carcinoma. Int J Cancer. 1996 Oct 9;68(2):164–171. doi: 10.1002/(sici)1097-0215(19961009)68:2<169::aid-ijc4>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  33. Vasmatzis G., Essand M., Brinkmann U., Lee B., Pastan I. Discovery of three genes specifically expressed in human prostate by expressed sequence tag database analysis. Proc Natl Acad Sci U S A. 1998 Jan 6;95(1):300–304. doi: 10.1073/pnas.95.1.300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Velculescu V. E., Zhang L., Vogelstein B., Kinzler K. W. Serial analysis of gene expression. Science. 1995 Oct 20;270(5235):484–487. doi: 10.1126/science.270.5235.484. [DOI] [PubMed] [Google Scholar]
  35. Weiner T. M., Liu E. T., Craven R. J., Cance W. G. Expression of focal adhesion kinase gene and invasive cancer. Lancet. 1993 Oct 23;342(8878):1024–1025. doi: 10.1016/0140-6736(93)92881-s. [DOI] [PubMed] [Google Scholar]
  36. Wittwer C. T., Ririe K. M., Andrew R. V., David D. A., Gundry R. A., Balis U. J. The LightCycler: a microvolume multisample fluorimeter with rapid temperature control. Biotechniques. 1997 Jan;22(1):176–181. doi: 10.2144/97221pf02. [DOI] [PubMed] [Google Scholar]
  37. Zachar V., Thomas R. A., Goustin A. S. Absolute quantification of target DNA: a simple competitive PCR for efficient analysis of multiple samples. Nucleic Acids Res. 1993 Apr 25;21(8):2017–2018. doi: 10.1093/nar/21.8.2017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Zhang L., Zhou W., Velculescu V. E., Kern S. E., Hruban R. H., Hamilton S. R., Vogelstein B., Kinzler K. W. Gene expression profiles in normal and cancer cells. Science. 1997 May 23;276(5316):1268–1272. doi: 10.1126/science.276.5316.1268. [DOI] [PubMed] [Google Scholar]
  39. el-Deiry W. S., Tokino T., Velculescu V. E., Levy D. B., Parsons R., Trent J. M., Lin D., Mercer W. E., Kinzler K. W., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell. 1993 Nov 19;75(4):817–825. doi: 10.1016/0092-8674(93)90500-p. [DOI] [PubMed] [Google Scholar]
  40. von Stein O. D., Thies W. G., Hofmann M. A high throughput screening for rarely transcribed differentially expressed genes. Nucleic Acids Res. 1997 Jul 1;25(13):2598–2602. doi: 10.1093/nar/25.13.2598. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES